Phase II Trial of Pentostatin and Targeted Busulfan

NCT00496340 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DRUG: Pentostatin
DRUG: Busulfan
DRUG: Rituximab
PROCEDURE: Allogeneic Hematopoietic Cell Transplant

Sponsor

H. Lee Moffitt Cancer Center and Research Institute